Feb, 19 2026
Paragraph IV Certifications: How Generics Challenge Drug Patents Early
Paragraph IV certifications let generic drug makers challenge brand-name drug patents before launch, saving billions in drug costs. Learn how the Hatch-Waxman Act enables this early patent challenge-and why it's changing the future of medicine.